{{Rsnum
|rsid=41507953
|Gene=EPHX2
|Chromosome=8
|position=27500988
|Orientation=plus
|GMAF=0.1001
|Gene_s=EPHX2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 86.7 | 11.5 | 1.8
| HCB | 99.3 | 0.7 | 0.0
| JPT | 0.0 | 0.0 | 0.0
| YRI | 61.2 | 32.7 | 6.1
| ASW | 57.9 | 33.3 | 8.8
| CHB | 99.3 | 0.7 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 83.2 | 16.8 | 0.0
| LWK | 58.2 | 31.8 | 10.0
| MEX | 89.7 | 10.3 | 0.0
| MKK | 64.7 | 31.4 | 3.8
| TSI | 84.3 | 13.7 | 2.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23711456
|Title=Variations in the human soluble epoxide hydrolase gene and recurrence of atrial fibrillation after catheter ablation
}}{{PMID Auto
|PMID=21429967
|Title=In vivo activity of epoxide hydrolase according to sequence variation affects the progression of human IgA nephropathy.
}}